Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma

NCT04020705 is registered in ClinicalTrials.gov with Istituto di Ricerca Neuroftalmologia S.r.l. as lead sponsor.

NCT NCT04020705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04020705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Citicoline in Eyedrops (OMK1) in Reducing the Progression of Glaucoma
Lead sponsor
Istituto di Ricerca Neuroftalmologia S.r.l.
Phase
Not applicable
Overall status
Completed
Start date
September 22, 2015
Completion date
March 19, 2019
Enrollment
90 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma